Conditions including autism, Alzheimer's disease, schizophrenia, bipolar disorder, depression, and diabetes are mitochondrial disorders that respond better to ketogenic diets than to any other current therapy.
"certain diseases like whether it's autism or Alzheimer's or schizophrenia or bipolar disease or depression, diabetes and these are all mitochondrial problems and they all respond extremely well to ketogenic diets. They respond better than any other current therapy." (said at 0:35:54)
The claim that autism, Alzheimer's disease, schizophrenia, bipolar disorder, depression, and diabetes 'respond better [to ketogenic diets] than to any other current therapy' is contradicted by clinical evidence. While ketogenic dietary interventions are being actively researched for metabolic and neuropsychiatric conditions—showing modest effects in depressive symptoms, cognitive outcomes in small trials, or glycemic control—current evidence does not show that ketogenic diets outperform standard first-line therapies (such as antipsychotics, mood stabilizers, psychotherapy, or standard diabetes medications). Systematic reviews consistently find that clinical evidence in psychiatric and neurodevelopmental conditions remains preliminary, heterogeneous, or derived largely from small, uncontrolled studies rather than superiority over established standard-of-care treatments.
- contradicts: Effectiveness of nutritional interventions on behavioral symptomatology of autism spectrum… (Nutricion hospitalaria 2022)
"the five types of nutritional interventions evaluated show varied evidence that does not allow defining the degree of effectiveness between one or the other in terms of behavioral improvements in the population with ASD." (abstract, conclusions, passage verified)
pubmedfull study (doi) - contradicts: Efficacy of low carbohydrate and ketogenic diets in treating mood and anxiety disorders: s… (BJPsych open 2023)
"Although there is no high-quality evidence of LC/KD efficacy in mood or anxiety disorders, several uncontrolled studies suggest possible beneficial effects. Robust studies are now needed to demonstrate efficacy, to identify clinical groups who may benefit and whether a ketogenic diet (beyond low carbohydrate) is required and to characterise adverse effects and the risk of relapse after diet discontinuation." (abstract, conclusions, passage verified)
pubmedfull study (doi) - contradicts: Ketogenic Diets and Depression and Anxiety: A Systematic Review and Meta-Analysis. (JAMA psychiatry 2026)
"In this systematic review and meta-analysis, KDs were associated with modest improvements in depressive symptoms, particularly with biochemical ketosis verification, while anxiety evidence was inconclusive. Given heterogeneity, comparators, and short follow-up, well-powered trials with standardized, verified protocols, structured support, and prespecified outcomes are needed to confirm efficacy and durability." (abstract, conclusions, passage verified)
pubmedfull study (doi)